THREE-MONTHS-OLD INFANT FOUND FOLLOWING ALLEGED CHILD STEALING IN LUSAKA. (PHOTO). #PRESS RELEASE

Image
 THREE-MONTHS-OLD INFANT FOUND FOLLOWING ALLEGED CHILD STEALING IN LUSAKA October 12, 2026 – The Zambia Police Service wishes to inform the public that a three-months-old female infant, who was allegedly stolen from her mother in  City Market area of Lusaka, has been found. Brief facts of the matter are that on October 9, 2026, at around 14:00 hours, Beatrice Lengalenga, a resident of Katondo area in Kabwe District and mother of the infant, was allegedly lured to travel to Lusaka by an unidentified female who purported to offer her employment. Upon arrival in City Market area of Lusaka, the mother, accompanied by the infant and the unidentified female, proceeded to a salon, where the mother was offered hairdressing services.  While the mother was having her hair done, the female offered to hold and look after the infant. She subsequently allegedly fled with the child without the mother's consent. Upon receiving the report, police officers immediately launched investigatio...

GSK SEEKS APPROVAL FOR WORLD'S FIRST MALARIA VACCINE.

A jogger runs past a signage for pharmaceutical giant GlaxoSmithKline (GSK) in London April 22, 2014. REUTERS/Luke MacGregor            According to sources,the company Glaxo Smith Kline {GSK} said today thursday that it is applying for regulatory approval for the world's first vaccine against malaria,designed for children in Africa.The British drugmaker said the shot called RTS,S,is intended exclusively for use outside the European union but will be evaluated by the European medicines Agency {EMA} in collaboration with World Health Organisation {WHO}.Malaria,a mosquito borne parastic disease,kills more than 600,000 people a year,mainly babies in the poorest parts of sub Saharan Africa.Experts have long hoped that scientists would be able to develop an effective vaccine against the disease,and scientists at GSK have been working on this one for 30 years.The WHO,has previously indicated it may recommend use of RTS,S from as early as 2015 if EMA drugs regulators back its license application.GSK has been developing RTS,S with the non profit PATH malaria vaccine initiative {MVI},with grant funding from the Bill and Melinda Gates foundation to MVI.The vaccine also contains an adjuvant,or booster,made by U.S biotech company Agenus,which received an undisclosed milestone payment for the regulatory submission.

Comments

Popular posts from this blog

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.